Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab
Clinical trial NCT04791215 · TERMINATED
Trial details
- NCT number
- NCT04791215
- Sponsor
- Columbia University
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-01
- Primary completion
- 2023-04-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.